These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30896361)
1. Modeling Vascular Risk Factors for the Development of Ischemic Stroke Therapies. Hermann DM; Kleinschnitz C Stroke; 2019 May; 50(5):1310-1317. PubMed ID: 30896361 [No Abstract] [Full Text] [Related]
2. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Cui LL; Golubczyk D; Tolppanen AM; Boltze J; Jolkkonen J Ann Neurol; 2019 Jul; 86(1):5-16. PubMed ID: 31020699 [No Abstract] [Full Text] [Related]
3. Considering risk factors for the effectiveness of translational therapies in brain stroke. Gutiérrez-Vargas JA; Cardona-Gómez GP J Neurol Sci; 2020 Jan; 408():116547. PubMed ID: 31683050 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNAs as Diagnostic and Therapeutic Targets for Ischemic Stroke. Wang Q; Liu X; Zhu R Curr Pharm Des; 2019; 25(10):1115-1121. PubMed ID: 30919772 [TBL] [Abstract][Full Text] [Related]
10. [Stroke: the review of the problem (15 years after)]. Suslina ZA; Piradov MA; Domashenko MA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):5-13. PubMed ID: 25591629 [TBL] [Abstract][Full Text] [Related]
11. Stroke and diabetes mellitus. Hill MD Handb Clin Neurol; 2014; 126():167-74. PubMed ID: 25410221 [TBL] [Abstract][Full Text] [Related]
12. Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis. Lee M; Ovbiagele B; Hong KS; Wu YL; Lee JE; Rao NM; Feng W; Saver JL Stroke; 2015 Jul; 46(7):1883-9. PubMed ID: 26022636 [TBL] [Abstract][Full Text] [Related]
19. TARGETING NEUROINFLAMMATION FOR TREATMENT OF ISCHEMIC STROKE. Kokaia Z Georgian Med News; 2015 Jun; (243):84-7. PubMed ID: 26087739 [TBL] [Abstract][Full Text] [Related]